Shenzhen New Industries Biomedical (300832) — Net Asset Quality Index
Shenzhen New Industries Biomedical (300832) has a Net Asset Quality Index of 91.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.58 Billion minus total liabilities of CN¥831.98 Million yields net assets of CN¥8.74 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 300832 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shenzhen New Industries Biomedical Net Asset Quality Index Over Time (2012–2024)
This chart shows how Shenzhen New Industries Biomedical's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 91.3%, representing net assets of CN¥8.74 Billion against total assets of CN¥9.58 Billion CNY. For live market cap and overall valuation, see 300832 market cap overview.
Annual Net Asset Quality Index for Shenzhen New Industries Biomedical (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Shenzhen New Industries Biomedical from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Shenzhen New Industries Biomedical to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.2% | CN¥8.58 Billion | CN¥9.62 Billion | CN¥1.04 Billion | ▼ -2.6 pp |
| 2023 | 91.8% | CN¥7.54 Billion | CN¥8.22 Billion | CN¥678.09 Million | ▲ +0.5 pp |
| 2022 | 91.2% | CN¥6.40 Billion | CN¥7.01 Billion | CN¥615.06 Million | ▼ -0.2 pp |
| 2021 | 91.5% | CN¥5.61 Billion | CN¥6.14 Billion | CN¥523.51 Million | ▲ +0.9 pp |
| 2020 | 90.5% | CN¥4.80 Billion | CN¥5.31 Billion | CN¥501.49 Million | ▼ -0.2 pp |
| 2019 | 90.8% | CN¥3.14 Billion | CN¥3.46 Billion | CN¥318.92 Million | ▲ +1.2 pp |
| 2018 | 89.6% | CN¥2.37 Billion | CN¥2.64 Billion | CN¥274.52 Million | ▲ +2.0 pp |
| 2017 | 87.6% | CN¥1.77 Billion | CN¥2.02 Billion | CN¥250.00 Million | ▼ -0.8 pp |
| 2016 | 88.4% | CN¥1.42 Billion | CN¥1.61 Billion | CN¥185.75 Million | ▼ -0.7 pp |
| 2015 | 89.1% | CN¥1.02 Billion | CN¥1.15 Billion | CN¥124.94 Million | ▲ +7.2 pp |
| 2014 | 81.9% | CN¥610.52 Million | CN¥745.44 Million | CN¥134.92 Million | ▲ +11.9 pp |
| 2013 | 70.0% | CN¥378.84 Million | CN¥540.96 Million | CN¥162.12 Million | ▼ -9.2 pp |
| 2012 | 79.3% | CN¥248.18 Million | CN¥313.11 Million | CN¥64.93 Million | — |